ST沈機(000410.SZ):定增事項獲通用技術集團批准
格隆匯3月1日丨ST沈機(000410.SZ)公佈,公司於2022年1月27日召開第九屆董事會第二十四次會議,審議通過了公司非公開發行A股股票相關議案。根據《上市公司國有股權監督管理辦法》(國務院國資委、財政部、中國證監會令第36號)等有關規定,公司該次非公開發行A股股票事宜由中國通用技術(集團)控股有限責任公司(簡稱“通用技術集團”)作為國務院國資委授權單位審批批准。
近日,公司收到通用技術集團下發的《中國通用技術(集團)控股有限責任公司董事會2022年第2次會議決議》文件,同意公司非公開發行股票整體方案及相關事項;公司非公開發行募資不超過15億元,通用技術集團全額認購,發行價格為3.94元/股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.